Trial reportPloS one2024
Validation of visual analog scales of mood and anxiety at the workplace.
Trial report in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
WittyFit - Live Your Work Differently
PeerOnCall: A Cluster Randomized Trial of a Peer Support Mobile Health Platform in Canadian Fire Service Organizations
Who cites it
11 citing papers in PubMed.
- Determinants of pain, anxiety and patient satisfaction during intravenous injection: a cross-sectional study.BMJ open · 2026Article
- Integrated gut microbiota and metabolome analyses link anger to metabolic dysregulation in patients with type 2 diabetes mellitus.Frontiers in microbiology · 2026Article
- Anxiety about recurrence or metastasis after nephrectomy and perspectives on and preferences for adjuvant therapy among patients with renal cell carcinoma in Japan: a cross-sectional web-based survey.Frontiers in oncology · 2026Article
- Understanding Pain Expression Using Visual Art: A Qualitative Study of the Artistic Pain Exploration Tool in Patients with Temporomandibular Disorder.Journal of pain research · 2026Article
- From traits to daily experiences: An adaptation of the Selflessness/Self-centeredness Inventory to day-level assessment.PloS one · 2026Article
- Evaluation of human body malodor using functional near-infrared spectroscopy with regions of interest based on functional pathways in the olfactory system.Frontiers in neuroscience · 2026Article
- Validation of visual analogue scales to assess occupational stress compared to the Karasek questionnaire: A cross sectional study.PloS one · 2026Observational
- Article
- Assessing the Effectiveness of a Solution-Focused Brief Therapy-Based Intervention on Exam Anxiety in First-Year Polish University Students: A Pilot Study with a Randomized Controlled Trial.Healthcare (Basel, Switzerland) · 2025Article
- Assessment of autonomic function in patient with COVID-19 and other infectious diseases using a wearable smart band connected to a mobile application.Frontiers in psychiatry · 2025Article
- Autonomic and physiological stress responses in navy divers: the protective role of diving experience.Frontiers in physiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Hospital Anxiety and Depression Scale (HADS) is commonly used to detect depressive or anxious states, but its 14-item questionnaire is time-consuming. Visual analog scales (VAS) are easy to use and quick to implement. Although the VAS has been validated to assess pain and occupational stress, VAS scores for anxiety and mood have never been evaluated in the workplace. We aimed to validate the use of visual analog scales (VAS) for anxiety and mood compared to HADS in workers. A HADS self-reported questionnaire associated with VAS assessing perceived anxiety and mood on a horizontal line of 100 mm was administered to 182 workers, with a second test (retest) proposed one week later. Sociodemographic, characteristics of work, sleep, well-being, and stress were also assessed. VAS anxiety and mood correlated with the HADS sub-scores (0.70 and 0.65, respectively). The test-retest reliability was good. Optimal VAS cut-offs were ≥ 60/100 for anxiety and ≤ 60/100 for mood, to define at-risk patients. The VAS is quick to perform, easy to use, and reliable for screening depression and anxiety in occupational medicine. We recommend validated questionnaires for at-risk patients.
trial registrationCLINICALTRIALS: gov: NCT02596737. Available at: https://www. CLINICALTRIALS: gov/ct2/show/NCT02596737.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.